Clinical trials
Completed Observational Thyroid Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| National Taiwan University Hospital | 3 |
| Chinese PLA General Hospital | 2 |
| Fujian Medical University | 2 |
| Hadassah Medical Organization | 2 |
| Jiangxi Provincial Cancer Hospital | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Shandong Provincial Hospital | 2 |
| University of Nebraska | 2 |
| Aristotle University Of Thessaloniki | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 95 |
| Thyroid Nodule | 15 |
| Thyroid Diseases | 9 |
| Breast Neoplasms | 6 |
| Neoplasms | 6 |
| Thyroid Cancer, Papillary | 4 |
| Brain Neoplasms | 3 |
| Goiter | 3 |
| Lymphatic Metastasis | 3 |
| Melanoma | 3 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.